{"pmid":32460417,"title":"COVID-19 - neurologists stay aware!","text":["COVID-19 - neurologists stay aware!","In December 2019 an epidemic outbreak of a new virus disease in the Chinese area of Wuhan was reported. The new disease caused primarily symptoms of a respiratory tract infection with cough, shortness of breath, and viral pneumonia. The clinical spectrum showed mostly mild symptoms with some patients developing bilateral pneumonia needing partly intensive care treatment and causing death(1). It became apparent, that this new disease was highly contagious, and - intensive care - patients numbers were rapidly rocketing, overwhelming the capacity of local health care facilities.","Eur J Neurol","von Oertzen, Tim J","32460417"],"abstract":["In December 2019 an epidemic outbreak of a new virus disease in the Chinese area of Wuhan was reported. The new disease caused primarily symptoms of a respiratory tract infection with cough, shortness of breath, and viral pneumonia. The clinical spectrum showed mostly mild symptoms with some patients developing bilateral pneumonia needing partly intensive care treatment and causing death(1). It became apparent, that this new disease was highly contagious, and - intensive care - patients numbers were rapidly rocketing, overwhelming the capacity of local health care facilities."],"journal":"Eur J Neurol","authors":["von Oertzen, Tim J"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460417","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/ene.14365","locations":["Chinese","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667967699017269248,"score":9.490897,"similar":[{"pmid":32417768,"title":"Zero tolerance for complacency by government of West African countries in the face of the COVID-19 pandemic.","text":["Zero tolerance for complacency by government of West African countries in the face of the COVID-19 pandemic.","A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.","Hum Antibodies","Erhabor, O","Erhabor, T","Adias, T C","Okara, G C","Retsky, M","32417768"],"abstract":["A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers."],"journal":"Hum Antibodies","authors":["Erhabor, O","Erhabor, T","Adias, T C","Okara, G C","Retsky, M"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417768","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3233/HAB-200413","keywords":["covid-19 pandemic","west africa","zero tolerance","complacency","government"],"locations":["Wuhan","China","West Africa","China","Italy","France","Spain","Iran","GBR","West African"],"countries":["Iran, Islamic Republic of","France","Italy","Spain","United Kingdom","China"],"countries_codes":["IRN|Iran, Islamic Republic of","FRA|France","ITA|Italy","ESP|Spain","GBR|United Kingdom","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667058206796414977,"score":120.11217},{"pmid":32351851,"pmcid":"PMC7187998","title":"A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.","text":["A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.","After an outbreak in December 2019 in Wuhan, Hubei Province of China, coronavirus disease 2019 (COVID-19) has rapidly become a pandemic. The 2019 novel coronavirus (2019 nCov), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a wide spectrum of illness and patients with underlying comorbidities have a high mortality. Here we present a 49-year-old male patient with comorbid conditions who presented with fever, cough, myalgia and shortness of breath for five days with likely exposure to a COVID-19 contact. A computed tomography scan of the thorax revealed multifocal bilateral ground-glass lung opacities with areas of subpleural sparing. He tested positive for SARS-CoV-2 by nucleic acid amplification. Hydroxychloroquine therapy was started, and the patient responded favorably with improvement of symptoms. Early diagnosis and self-isolation or quarantine remain key to stemming the tide of the contagion as there is a real risk of the healthcare system being overwhelmed.","Cureus","Mukherjee, Aveek","Ahmad, Mudassar","Frenia, Douglas","32351851"],"abstract":["After an outbreak in December 2019 in Wuhan, Hubei Province of China, coronavirus disease 2019 (COVID-19) has rapidly become a pandemic. The 2019 novel coronavirus (2019 nCov), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a wide spectrum of illness and patients with underlying comorbidities have a high mortality. Here we present a 49-year-old male patient with comorbid conditions who presented with fever, cough, myalgia and shortness of breath for five days with likely exposure to a COVID-19 contact. A computed tomography scan of the thorax revealed multifocal bilateral ground-glass lung opacities with areas of subpleural sparing. He tested positive for SARS-CoV-2 by nucleic acid amplification. Hydroxychloroquine therapy was started, and the patient responded favorably with improvement of symptoms. Early diagnosis and self-isolation or quarantine remain key to stemming the tide of the contagion as there is a real risk of the healthcare system being overwhelmed."],"journal":"Cureus","authors":["Mukherjee, Aveek","Ahmad, Mudassar","Frenia, Douglas"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32351851","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7759/cureus.7473","keywords":["2019 novel coronavirus","2019-ncov","cov","covid-19","ground-glass opacity","hydroxychloroquine","multifocal","pneumonia","sars-cov-2 (severe acute respiratory syndrome coronavirus -2)","wuhan"],"locations":["Wuhan","Hubei","China","myalgia","Hydroxychloroquine","Hydroxychloroquine"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Hydroxychloroquine"],"topics":["Case Report"],"weight":1,"_version_":1666138495571197952,"score":112.79569},{"pmid":32291376,"title":"Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.","text":["Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.","Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease caused by SARS- CoV-2 which was first identified as outbreak of unknown respiratory illness in Wuhan, China. COVID- 19 was declared as global health emergency by WHO on March 11, 2020 and quickly elevated to global pandemic on 11 March 2020. COVID-19 symptom is highly various in each patient, with fever, fatigue, shortness of breath, and cough as the main presenting symptoms. Patient with COVID-19 may shows severe symptom with severe pneumonia and ARDS, mild symptom resembling simple upper respiration tract infection, or even completely asymptomatic. Approximately 80% of cases is mild. However the number may changes as more people are getting tested. Some experts are estimating that up to 50% of all cases may be asymptomatic carrier.","Acta Med Indones","Burhan, Erlina","Prasenohadi, Prasenohadi","Rogayah, Rita","Isbaniyah, Fathiyah","Reisa, Tina","Dharmawan, Ibrahim","32291376"],"abstract":["Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease caused by SARS- CoV-2 which was first identified as outbreak of unknown respiratory illness in Wuhan, China. COVID- 19 was declared as global health emergency by WHO on March 11, 2020 and quickly elevated to global pandemic on 11 March 2020. COVID-19 symptom is highly various in each patient, with fever, fatigue, shortness of breath, and cough as the main presenting symptoms. Patient with COVID-19 may shows severe symptom with severe pneumonia and ARDS, mild symptom resembling simple upper respiration tract infection, or even completely asymptomatic. Approximately 80% of cases is mild. However the number may changes as more people are getting tested. Some experts are estimating that up to 50% of all cases may be asymptomatic carrier."],"journal":"Acta Med Indones","authors":["Burhan, Erlina","Prasenohadi, Prasenohadi","Rogayah, Rita","Isbaniyah, Fathiyah","Reisa, Tina","Dharmawan, Ibrahim"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291376","source":"PubMed","week":"202016|Apr 13 - Apr 19","keywords":["covid-19, sars, cov-2-"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494324441088,"score":112.71002},{"pmid":32324362,"title":"[Practical aspects of intensive care for critically ill COVID-19 patients requiring respiratory support].","text":["[Practical aspects of intensive care for critically ill COVID-19 patients requiring respiratory support].","In December 2019, a novel outbreak of pneumonia was reported in Wuhan city, China. Initially, the zoonitic infection spread from human to human, causing a pandemic. This viral disease (COVID-19) can appear in a variety of forms, from asymptomatic through the spectrum of mild symptoms to severe respiratory failure, requiring intensive care. Caring for this latter group of patients puts a significant burden on health care. The purpose of this summary is to present the practical aspects of intensive care for patients requiring respiratory support and mechanical ventilation. Orv Hetil. 2020; 161(17): 678-684.","Orv Hetil","Vegh, Tamas","Laszlo, Istvan","Juhasz, Marianna","Berhes, Mariann","Fabian, Akos","Koszta, Gyorgy","Molnar, Csilla","Fulesdi, Bela","32324362"],"abstract":["In December 2019, a novel outbreak of pneumonia was reported in Wuhan city, China. Initially, the zoonitic infection spread from human to human, causing a pandemic. This viral disease (COVID-19) can appear in a variety of forms, from asymptomatic through the spectrum of mild symptoms to severe respiratory failure, requiring intensive care. Caring for this latter group of patients puts a significant burden on health care. The purpose of this summary is to present the practical aspects of intensive care for patients requiring respiratory support and mechanical ventilation. Orv Hetil. 2020; 161(17): 678-684."],"journal":"Orv Hetil","authors":["Vegh, Tamas","Laszlo, Istvan","Juhasz, Marianna","Berhes, Mariann","Fabian, Akos","Koszta, Gyorgy","Molnar, Csilla","Fulesdi, Bela"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324362","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1556/650.2020.31810","keywords":["covid-19 patients","covid-19-fertozott beteg","gepi lelegeztetes","intensive care","intenziv terapia","legzesi elegtelenseg","legzestamogatas","mechanical ventilation","respiratory insufficiency","respiratory support"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493795958784,"score":111.90975},{"pmid":32323891,"title":"The need for neurologists in the care of COVID-19 patients.","text":["The need for neurologists in the care of COVID-19 patients.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulting in severe acute respiratory syndrome in a substantial number of patients. Approximately 5% to 10% of patients need intensive care unit (ICU) admission and mechanical ventilation [1]. The primary symptoms of COVID-19 include fever, dry cough and fatigue [2]. However, a recent report from Shandong, China, disclosed that a subset of patients did not suffer from respiratory symptoms but had neurologic signs and symptoms [3]. Moreover, in a retrospective study from Wuhan, China, neurologic symptoms were observed in 36.4% of the hospitalized patients with COVID-19 infection and pertained to both the central and peripheral nervous system [4].","Eur J Neurol","Sellner, Johann","Taba, Pille","Ozturk, Serefnur","Helbok, Raimund","32323891"],"abstract":["Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulting in severe acute respiratory syndrome in a substantial number of patients. Approximately 5% to 10% of patients need intensive care unit (ICU) admission and mechanical ventilation [1]. The primary symptoms of COVID-19 include fever, dry cough and fatigue [2]. However, a recent report from Shandong, China, disclosed that a subset of patients did not suffer from respiratory symptoms but had neurologic signs and symptoms [3]. Moreover, in a retrospective study from Wuhan, China, neurologic symptoms were observed in 36.4% of the hospitalized patients with COVID-19 infection and pertained to both the central and peripheral nervous system [4]."],"journal":"Eur J Neurol","authors":["Sellner, Johann","Taba, Pille","Ozturk, Serefnur","Helbok, Raimund"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323891","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ene.14257","keywords":["covid-19","sars-cov-2","autonomic dysfunction","encephalitis","neurological complications","olfactory bulb","stroke"],"locations":["Shandong","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493771841537,"score":111.36468}]}